Enveric Biosciences, Inc. (ENVB) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Naples, FL, 미국. 현재 CEO는 Joseph Edward Tucker.
ENVB 을(를) 보유 IPO 날짜 2015-05-04, 5 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $1.16M.
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
